Notable Upgrades: Abraxas Petroleum (AXAS), UnitedHealth Group (UNH), Textron (TXT), Marvell Technology (MRVL), The Carlyle Group (CG)

Analysts at Canaccord Genuity are out with a report this morning upgrading shares of Abraxas Petroleum Corp. (AXAS) with a ‘Buy‘ from ‘Hold‘ rating. The firm raised its price target for the company to $3.75 from $3.25.

Abraxas Petroleum Corp. shares are currently priced at 5.43x this year’s forecasted earnings, which makes them quite inexpensive compared to the industry’s 11.35x earnings multiple. Ticker has a forward P/E of 15.57 and t-12 price-to-sales ratio of 2.43. EPS for the same period is $0.61.

In the past 52 weeks, shares of San Antonio, Texas-based oil company have traded between a low of $2.33 and a high of $6.45 and are now at $3.32. Shares are down 5.18% year-over-year ; up 5.78% year-to-date.

Analysts at Sterne Agee upgraded their rating on the shares of UnitedHealth Group Incorporated (UNH). In a research note published on Friday, the firm lifted the name with a ‘Neutral‘ from ‘Underperform‘ rating and set a 12-month base case estimate of $126 from $105 per share.

On valuation measures, UnitedHealth Group Inc. shares are currently priced at 19.80x this year’s forecasted earnings compared to the industry’s 20.36x earnings multiple. Ticker has a PEG and forward P/E ratio of 1.91 and 16.14, respectively. Price/Sales for the same period is 0.84 while EPS is $5.70. Currently there are 19 analysts that rate UNH a ‘Buy’, 5 rate it a ‘Hold’. 1 analyst rates it a ‘Sell’. UNH has a median Wall Street price target of $124.50 with a high target of $149.00.

Textron Inc. (TXT) was raised to ‘Buy‘ from ‘Neutral‘ at Nomura on Friday.

TXT is up $0.76 at $44.77 on heavy volume. Midway through trading Friday, 1.63 million shares of Textron Inc. have exchanged hands as compared to its average daily volume of 2.00 million shares. The stock has been ranging intraday between $44.09-$45.27 after having opened the day at $44.37 as compared to the previous trading day’s close of $44.01.

In the past 52 weeks, shares of the American industrial conglomerate have traded between a low of $32.22 and a high of $45.61. Shares are up 10.33% year-over-year and 4.51% year-to-date.

Marvell Technology Group Ltd. (MRVL) was upgraded to ‘Positive‘ from ‘Neutral‘ by Susquehanna analysts on Friday. The broker also raised its price target on the stock to $20 from $14 – implying 43% expected return.

MRVL is currently printing a higher than average trading volume with the issue trading 5.21 million shares, compared to the average volume of 7.78 million. The stock began trading this morning at $16.71 to currently trade 0.42% higher from the prior days close of $16.51. On an intraday basis it has gotten as low as $16.49 and as high as $16.77.

Marvell Technology Group Ltd. shares are priced at 19.74x this year’s forecasted earnings, compared to the industry’s 17.79x earnings multiple. The company’s current year and next year EPS growth estimates stand at (13.9%) and 11.10% compared to the industry growth rates of 25.50% and 26.30%, respectively. MRVL has a t-12 price-to-sales ratio of 2.29. EPS for the same period registers at $0.84.

Marvell Tech shares have advanced 3.58% in the last 4 weeks and 14.34% in the past three months. Over the past 5 trading sessions the stock has gained 2.55%.

The producer of storage, communications and consumer semiconductor products, which is currently valued at $8.52 billion, has a median Wall Street price target of $15.88 with a high target of $21.00. Marvell Technology Group Ltd. is up 6.65% year-over-year, compared with a 11.87% gain in the S&P 500.

Analysts at Bank of America (BAC) upgraded their rating on the shares of The Carlyle Group LP (CG). In a research note published on Friday, the firm lifted the name with a ‘Buy‘ from ‘Neutral‘ rating and set a 12-month base case estimate of $32 from $30 per share.

The Carlyle Group shares recently gained $0.23 to $27.20. In the past 52 weeks, shares of Washington DC-based investment firm have traded between a low of $24.42 and a high of $35.99. Currently there are 9 analysts that rate CG a ‘Buy’, 5 rate it a ‘Hold’. 0 analysts rates it a ‘Sell’. CG has a median Wall Street price target of $32.00 with a high target of $38.00.

Shares are down 20.42% year-over-year and 1.93% year-to-date.

Be the first to comment

Leave a Reply

Your email address will not be published.


*